Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group

The Branch Vein Occlusion Study is a multicenter, randomized, controlled clinical trial designed to answer several questions regarding the management of complications of branch vein occlusion. This report addresses the questions, "Can peripheral scatter argon laser photocoagulation prevent the development of neovascularization?" and "Can peripheral scatter argon laser photocoagulation prevent vitreous hemorrhage?" To answer the first question, 319 eyes were assigned randomly to either a treated or an untreated control group. Comparing treated patients with control patients (average follow-up time, 3.7 years), the development of neovascularization was significantly less in treated eyes (P = .009, log rank test). To answer the second question, 82 eyes were assigned randomly to either a treated or untreated control group. Comparing treated patients with control patients (average follow-up time, 2.8 years), the development of vitreous hemorrhage was significantly less in treated eyes (P = .005, log rank test). Although the Branch Vein Occlusion Study was not designed to determine whether peripheral scatter treatment should be applied before rather than after the development of neovascularization, data accumulated in this study suggest that peripheral scatter treatment should be applied after the development of neovascularization rather than before the development of neovascularization. Because the occurrence of vitreous hemorrhage was lessened by peripheral scatter argon laser photocoagulation, we recommend laser photocoagulation for patients with branch vein occlusion who have developed neovascularization and who meet the eligibility criteria of this study.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The 15-Year Cumulative Incidence of Retinal Vein Occlusion: The Beaver Dam Eye Study
Klein et al.
Arch Ophthalmol 2008;126:513-518.
ABSTRACT | FULL TEXT  

The management of retinal vein occlusion: is interventional ophthalmology the way forward?
Shahid et al.
Br. J. Ophthalmol. 2006;90:627-639.
ABSTRACT | FULL TEXT  

Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy
Finger and Kurli
Br. J. Ophthalmol. 2005;89:730-738.
ABSTRACT | FULL TEXT  

Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial
Mirshahi et al.
Br. J. Ophthalmol. 2005;89:64-69.
ABSTRACT | FULL TEXT  

A New Treatment for Ocular Neovascularization
Ferris
NEJM 2004;351:2863-2865.
FULL TEXT  

Experimental Retinal Vein Occlusion: Effect of Acetazolamide and Carbogen (95% O2/5% CO2) on Preretinal PO2
Pournaras et al.
IOVS 2004;45:3669-3677.
ABSTRACT | FULL TEXT  

Effect of Laser Photocoagulation on the Retinal Vessel Diameter in Branch and Macular Vein Occlusion
Maar et al.
Arch Ophthalmol 2004;122:987-991.
ABSTRACT | FULL TEXT  

Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion
Chen et al.
Br. J. Ophthalmol. 1998;82:162-167.
ABSTRACT | FULL TEXT  

Laser-Induced Chorioretinal Venous Anastomosis for Nonischemic Central or Branch Retinal Vein Occlusion
Fekrat et al.
Arch Ophthalmol 1998;116:43-52.
ABSTRACT | FULL TEXT